|
|
|
|
B-902 / B-902-1ML updated item number format
Buprenorphine
100 ug/mL in Methanol | Certified Reference Material
|
|
Sold under the trade names Buprenex, Subutex and Suboxone, buprenorphine is an opiate drug used to treat opioid addiction and moderate acute pain. This certified solution standard is suitable for GC/MS or LC/MS applications in forensic analysis, clinical toxicology or pharmaceutical research.
|
|
|
|
|
| Concentration:
|
100 ug/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
52485-79-7
|
| Chemical Formula:
|
C29H41NO4
|
| Molecular Weight:
|
467.64
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| B-035 / B-035-1ML |
|
Buprenorphine-3ß-D-glucuronide, 100 μg/mL
|
|
$293.00
|
|
|
|
|
|
| B-044 / B-044-1ML |
|
Buprenorphine, 1.0 mg/mL
|
|
$154.00
|
|
|
|
|
|
| B-060 / B-060-1ML |
|
Buprenorphine-D4-3-β-D-glucuronide, 100 μg/mL
|
|
$342.00
|
|
|
|
|
|
| B-901 / B-901-1ML |
|
Buprenorphine-D4, 100 μg/mL
|
|
$46.90
|
|
|
|
|
|
| B-908 / B-908-1ML |
|
Buprenorphine-D4, 1.0 mg/mL
|
|
$403.00
|
|
|
|
|
|
| N-045 / N-045-1ML |
|
Norbuprenorphine glucuronide, 100 μg/mL
|
|
$284.00
|
|
|
|
|
|
| N-059 / N-059-1ML |
|
Norbuprenorphine, 1.0 mg/mL
|
|
$428.00
|
|
|
|
|
|
| N-097 / N-097-1ML |
|
Norbuprenorphine glucuronide-D3, 100 µg/mL
|
|
$306.00
|
|
|
|
|
|
| N-912 / N-912-1ML |
|
Norbuprenorphine, 100 μg/mL
|
|
$38.80
|
|
|
|
|
|
| N-920 / N-920-1ML |
|
Norbuprenorphine-D3, 100 μg/mL
|
|
$46.90
|
|
|
|
|
|
| N-921 / N-921-1ML |
|
Norbuprenorphine-D3, 1.0 mg/mL
|
|
$403.00
|
|
|
|
|
|
| P-071 / P-071-1ML |
|
Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl
|
|
$449.00
|
|
|
|
|
Regulatory Control
▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶ Canada Test Kit Registration # 61-1069 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
HS Code
3822.90.0000
|
▶ A High-throughput Pain Management Panel in Urine Using IONICS 3Q 120 LC-MS/MS and an SLE Sample Prep Platform | IONICS Mass Spectrometry Group inc., 2014
|
|
▶ Development of a high-throughput LC-MS/MS assay for pain management panel from urine | Hui Qiao, Changtong Hao, Sha Joshua Ye, Lisa Cousins, IONICS Mass Spectrometry Group inc., 2014
|
|
▶ Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
|
|
▶ Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µElution SPE Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
|
|
▶ High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
|
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
|
▶ Ultrafast Analysis of Buprenorphine and Norbuprenorphine in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System | Mohamed Youssef and Vaughn P. Miller, Agilent Technologies, Inc., 2013
|
|
|
|
|